Found 14 matching trials
Efficacy and Safety of Induction Benmelstobart Plus Anlotinib and Chemotherapy Followed by Concurrent Chemoradiotherapy and Benmelstobart Maintenance Versus Concurrent Chemoradiotherapy Followed by Benmelstobart Maintenance in Patients With Unresectable Stage III NSCLC PHASE2 The goal of this clinical trial is to compare the efficacy and safety of in...
Show More Learn More & Join Trial
This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer PHASE2 A total of 66 patients were enrolled in this exploratory study and randomly...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC PHASE2 To explore the Objective Response Rate (ORR) of Benmelstobart combined with...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer PHASE4 The goal of this clinical trial is to evaluate the efficacy and safety of b...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03) PHASE2 Our center plans to conduct a prospective, single-arm exploratory clinical ...
Show More Location
Hangzhou Cancer Hospital
Learn More & Join Trial
Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer PHASE2 Exploring the Safety and Efficacy of Benmelstobart Combined with Anlotinib ...
Show More Location
Affiliated Stomatological Hospital of Nanjing Medical University
Learn More & Join Trial
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma PHASE3 This trial aimed to evaluate the efficacy of anlotinib hydrochloride combin...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer PHASE2 This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Show More Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Learn More & Join Trial
Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer PHASE2 This is a single-arm, single-center, exploratory clinical study conducted a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma PHASE3 A Randomized, Open-Label, Parallel-Controlled, Multicenter Phase III Clinic...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial